Table 4 Treatment in the SLE patients at time-point of blood sampling
Groups | Patient group I n = 84 | Patient group II n = 140 |
|---|---|---|
Glukocorticoid dose ≤ 20 mg (n) | 38 | 91 |
Glucocorticoid dose > 20 mg (n) | 20 | 1 |
Antimalarial treatment (n) | 43 | 100 |
Azathioprine (n) | 18 | 31 |
Mycophenolatmofetil (n) | 1 | 19 |
Intravenous immunoglobulin disorder (n) | 3 | 2 |
Cyclophosphamide (n) | 3 | 0 |
Cyclosporine (n) | 5 | 2 |
Methotrexate (n) | 0 | 13 |